미국의 아이케어 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 구입 형태별, 유통 채널별, 부문별 예측(2025-2030년)

U.S. Eye Care Market Size & Trends:

The U.S. eye care market size was estimated at USD 27.3 billion in 2024 and is expected to grow at a CAGR of 7.1% from 2025 to 2030, driven by a rising prevalence of vision disorders such as myopia, glaucoma, and cataracts. An aging population, with over 54 million adults aged 65 and older, contributes to increased demand for eye care services and products. Technological advancements, including minimally invasive surgical devices and advanced diagnostic tools, are enhancing treatment outcomes. Growing awareness of preventive eye care and the increasing adoption of digital devices are fueling demand for solutions like blue-light-blocking lenses. The U.S. market is further supported by robust healthcare infrastructure and strong investments in ophthalmic research and innovation.

In September 2023, Bausch + Lomb launched its Lumify Eye Illuminations line, featuring hypoallergenic products such as micellar cleansing water, lash and brow serum, and hydra-gel brightening cream. Developed with ophthalmologists and dermatologists, the line prioritizes safety, as demonstrated in over 15,000 applications. Free from harsh chemicals such as parabens, sulfates, and alcohol, these products address growing consumer preferences for gentle, effective eye care solutions.

Another notable development in the U.S. eye care market is the introduction of Iridex Corp's next-generation Iridex 532 and Iridex 577 lasers. Launched in conjunction with the company's 35th anniversary, these advanced platforms incorporate patented MicroPulse Technology and offer multiple treatment modes to address retinal disorders and glaucoma. Featuring an intuitive touchscreen interface, these lasers enhance clinical control and improve treatment precision. The announcement was made ahead of the Hawaiian Eye and Retina 2024 meeting, underscoring Iridex's commitment to innovation and its legacy of providing reliable laser systems to ophthalmologists worldwide. According to David Bruce, President and CEO of Iridex, these lasers represent a pivotal step forward, combining cutting-edge technology with user-centric design to optimize patient care.

In addition, advancements in diagnostic tools and treatment options, such as minimally invasive surgical devices and personalized therapies, are transforming the landscape of eye care. Consumer demand for products that address both functional and cosmetic needs is also shaping market trends. For instance, hypoallergenic and nutrient-enriched products, such as Lumify Eye Illuminations, cater to the growing preference for solutions that are both effective and gentle.

U.S. Eye Care Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. eye care market report based on product, mode of purchase, and distribution channel:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Contact Lenses
• Intraocular Lenses
• Ocular Health Products
• Others
• Mode Of Purchase Outlook (Revenue, USD Million, 2018 - 2030)
• Prescribed (Rx) Products
• Over The Counter (OTC) Products
• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals & Clinics
• Retail Stores
• Online Stores
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Eye Care Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
    • 3.3.1.1. Aging Population
    • 3.3.1.2. Technological advancements
    • 3.3.1.3. Rising consumer awareness
  • 3.3.2. Market Restraints Analysis
    • 3.3.2.1. High treatment costs
    • 3.3.2.2. Healthcare disparities
• 3.4. U.S. U.S. Eye Care Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. U.S. Eye Care Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Eye Care Market: Product Movement Analysis, USD Million, 2024 & 2030
• 4.3. Contact Lenses
  • 4.3.1. Contact Lenses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Intraocular Lenses
  • 4.4.1. Intraocular Lenses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Ocular Health Products
  • 4.5.1. Ocular Health Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Eye Care Market: Mode Of Purchase Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Eye Care Market: Mode Of Purchase Movement Analysis, USD Million, 2024 & 2030
• 5.3. Prescribed (Rx) Products
  • 5.3.1. Prescribed (Rx) Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Over The Counter (OTC) Products
  • 5.4.1. Over The Counter (OTC) Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Eye Care Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Eye Care Market: Distribution Channel Movement Analysis, USD Million, 2024 & 2030
• 6.3. Hospitals & Clinics
  • 6.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Online Stores
  • 6.4.1. Online Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Retail Stores
  • 6.5.1. Retail Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Alcon, Inc.
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Johnson and Johnson Eye Care, Inc.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Bausch & Lomb Incorporated
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Carl Zeiss Meditec AG (ZEISS International)
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Essilor International
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. CooperVision
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. HOYA CORPORATION
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Rayner
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Product benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. STAAR SURGICAL
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Product benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. Novartis AG
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Product benchmarking
    • 7.4.10.4. Strategic initiatives